“On to Cincinnati” and more wisdom from our own Dr. Joan Mannick on the @PharmaVOICE WoW podcast with Taren Grom #BostonBiotech #WomeninBiotech pharmavoice.com/wow-podcasts/w…

We’re excited to share another significant milestone: enrollment was completed early for PROTECTOR 1, the first of two Phase 3 clinical trials in clinically symptomatic respiratory illness: ir.restorbio.com/news-releases/…

Our co-founder and chief medical officer, Dr. Joan Mannick, shares with MIT Technology Review how "turning down the mTOR pathway to younger levels may be of benefit in aging-related diseases." Read the full article: technologyreview.com/s/614154/the-a…

The Medicine Maker published an article on what inspires our Chief Medical Officer, Joan Mannick, M.D. It is this inspiration that drives employees at resTORbio every day. Read the full article.

We look forward to speaking next week at MIT Technology Review's #EmTechMIT, which will showcase new technologies that have the potential to disrupt existing industries, create entirely new markets, and change society.

We're speaking today with innovators across industries about our work in aging science at MIT Technology Review’s #EmTech MIT.

resTORbio to Present Findings on Investigational TORC1 Inhibitor RTB101 in Late-Breaking Session at IDWeek™ 2019 cutt.ly/QwM8m10

Attending #IDWeek2019? We’re presenting on our scientific strategy at a late-breaking session on Thursday. Join us! ir.restorbio.com/news-releases/…

We're sharing data on leveraging the immune system to defend against viruses that cause illnesses associated with RTIs at #IDWeek2019. Learn more. ir.restorbio.com/news-releases/…

ICYMI: resTORbio joined the world’s infectious disease experts at #IDWeek2019 to share our data on bolstering immune function to defend against respiratory illness caused by a variety of viruses. Read more: cutt.ly/0euf1tn

We're meeting with scientific leaders this week to talk about Metabesity: aging as the central link across a range of chronic diseases. #metabesity2019 metabesity2019.com

Cold and flu season has officially arrived. Think about preventive health strategies to reduce the risk of respiratory illnesses. cdc.gov/flu/season/

It's Respiratory Care Week! #RCWEEK19 We are proud to be part of the research community's efforts to combat respiratory illnesses.

At resTORbio, we are targeting the biology of aging. The goal is to boost immune defense against infectious disease, to potentially reduce some of the most prevalent diseases that affect the elderly. Learn more. restorbio.com

We're honored to join the best minds at the Milken Institute's Future of Health Summit this week to dive into the science of aging. #MIHealthSummit Milken Institute bit.ly/2WhYMDf

Turning Back Time: The Science of Aging at the Milken Institute #MIHealthSummit “Aging is a modifiable risk factor”

We’re in Bethesda this week for the third NIH #Geroscience Summit to explore opportunities at the intersection between aging and the biology of diseases.

We need to work together to make real impact. Our work, combined with collaboration and data sharing across the scientific community, will be the real accelerator to advance patient care.

Pneumonia can cause severe complications among the elderly. This World Pneumonia Day, learn more about research to reduce respiratory infections that can lead to pneumonia. #WorldPneumoniaDay2019 bit.ly/34WiTde